Exercise as an anabolic stimulus for bone

Charles H. Turner, Alexander Robling

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Mechanical loading provides an anabolic stimulus for bone. More importantly, the mechanosensing apparatus in bone directs osteogenesis to where it is most needed for improving bone strength. The biological processes involved in bone mechanotransduction are poorly understood and further investigation of the molecular mechanisms might uncover drug targets for osteoporosis. Several pathways are emerging from current research, including membrane ion channels, ATP signaling, and second messengers such as prostaglandins and nitric oxide. Some key molecular targets include the L-type calcium channel (alpha 1C isoform), a gadolinium-sensitive stretch-activated channel, P2Y2 and P2X7 purinergic receptors, EP2 and EP4 prostanoid receptors, and the parathyroid hormone receptor. One characteristic of the mechanosensing apparatus that has only recently been studied is the important role of desensitization. Experimental protocols that insert "rest" periods to reduce the effects of desensitization can double anabolic responses to mechanical loading. A drug therapy that suppresses desensitization pathways may provide an effective means to build bone strength.

Original languageEnglish (US)
Pages (from-to)2629-2641
Number of pages13
JournalCurrent Pharmaceutical Design
Volume10
Issue number21
DOIs
StatePublished - 2004

Fingerprint

Bone and Bones
Ion Channels
Receptors, Prostaglandin E, EP2 Subtype
Receptors, Prostaglandin E, EP4 Subtype
Purinergic P2Y2 Receptors
Parathyroid Hormone Receptor Type 1
Purinergic P2X7 Receptors
Biological Phenomena
L-Type Calcium Channels
Gadolinium
Second Messenger Systems
Osteogenesis
Osteoporosis
Prostaglandins
Nitric Oxide
Protein Isoforms
Adenosine Triphosphate
Drug Therapy
Research
Pharmaceutical Preparations

Keywords

  • Bone density
  • Bone strength
  • Desensitization
  • Nitric oxide
  • Osteoporosis
  • Parathyroid hormone
  • Prostaglandin
  • Purinergic receptors

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Exercise as an anabolic stimulus for bone. / Turner, Charles H.; Robling, Alexander.

In: Current Pharmaceutical Design, Vol. 10, No. 21, 2004, p. 2629-2641.

Research output: Contribution to journalArticle

Turner, Charles H. ; Robling, Alexander. / Exercise as an anabolic stimulus for bone. In: Current Pharmaceutical Design. 2004 ; Vol. 10, No. 21. pp. 2629-2641.
@article{5c48d125ba694950a468b844e47ce52a,
title = "Exercise as an anabolic stimulus for bone",
abstract = "Mechanical loading provides an anabolic stimulus for bone. More importantly, the mechanosensing apparatus in bone directs osteogenesis to where it is most needed for improving bone strength. The biological processes involved in bone mechanotransduction are poorly understood and further investigation of the molecular mechanisms might uncover drug targets for osteoporosis. Several pathways are emerging from current research, including membrane ion channels, ATP signaling, and second messengers such as prostaglandins and nitric oxide. Some key molecular targets include the L-type calcium channel (alpha 1C isoform), a gadolinium-sensitive stretch-activated channel, P2Y2 and P2X7 purinergic receptors, EP2 and EP4 prostanoid receptors, and the parathyroid hormone receptor. One characteristic of the mechanosensing apparatus that has only recently been studied is the important role of desensitization. Experimental protocols that insert {"}rest{"} periods to reduce the effects of desensitization can double anabolic responses to mechanical loading. A drug therapy that suppresses desensitization pathways may provide an effective means to build bone strength.",
keywords = "Bone density, Bone strength, Desensitization, Nitric oxide, Osteoporosis, Parathyroid hormone, Prostaglandin, Purinergic receptors",
author = "Turner, {Charles H.} and Alexander Robling",
year = "2004",
doi = "10.2174/1381612043383755",
language = "English (US)",
volume = "10",
pages = "2629--2641",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "21",

}

TY - JOUR

T1 - Exercise as an anabolic stimulus for bone

AU - Turner, Charles H.

AU - Robling, Alexander

PY - 2004

Y1 - 2004

N2 - Mechanical loading provides an anabolic stimulus for bone. More importantly, the mechanosensing apparatus in bone directs osteogenesis to where it is most needed for improving bone strength. The biological processes involved in bone mechanotransduction are poorly understood and further investigation of the molecular mechanisms might uncover drug targets for osteoporosis. Several pathways are emerging from current research, including membrane ion channels, ATP signaling, and second messengers such as prostaglandins and nitric oxide. Some key molecular targets include the L-type calcium channel (alpha 1C isoform), a gadolinium-sensitive stretch-activated channel, P2Y2 and P2X7 purinergic receptors, EP2 and EP4 prostanoid receptors, and the parathyroid hormone receptor. One characteristic of the mechanosensing apparatus that has only recently been studied is the important role of desensitization. Experimental protocols that insert "rest" periods to reduce the effects of desensitization can double anabolic responses to mechanical loading. A drug therapy that suppresses desensitization pathways may provide an effective means to build bone strength.

AB - Mechanical loading provides an anabolic stimulus for bone. More importantly, the mechanosensing apparatus in bone directs osteogenesis to where it is most needed for improving bone strength. The biological processes involved in bone mechanotransduction are poorly understood and further investigation of the molecular mechanisms might uncover drug targets for osteoporosis. Several pathways are emerging from current research, including membrane ion channels, ATP signaling, and second messengers such as prostaglandins and nitric oxide. Some key molecular targets include the L-type calcium channel (alpha 1C isoform), a gadolinium-sensitive stretch-activated channel, P2Y2 and P2X7 purinergic receptors, EP2 and EP4 prostanoid receptors, and the parathyroid hormone receptor. One characteristic of the mechanosensing apparatus that has only recently been studied is the important role of desensitization. Experimental protocols that insert "rest" periods to reduce the effects of desensitization can double anabolic responses to mechanical loading. A drug therapy that suppresses desensitization pathways may provide an effective means to build bone strength.

KW - Bone density

KW - Bone strength

KW - Desensitization

KW - Nitric oxide

KW - Osteoporosis

KW - Parathyroid hormone

KW - Prostaglandin

KW - Purinergic receptors

UR - http://www.scopus.com/inward/record.url?scp=3242877031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242877031&partnerID=8YFLogxK

U2 - 10.2174/1381612043383755

DO - 10.2174/1381612043383755

M3 - Article

VL - 10

SP - 2629

EP - 2641

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 21

ER -